Table 1 Baseline characteristics of pediatric patients with severe uncontrolled asthma (N = 36) treated at a referral center for asthma in Brazil
From: Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study
Variable | n (%) | Median (IQR) |
|---|---|---|
Female gender | 23 (63.9) | |
Age (years) | 11.6 (6.2 to 17.8) | |
Height (Z score) | 0.05 (−2.66 to 1.00) | |
BMI (Z score) | −0.48 (−2.90 to 1.84) | |
Well-controlled home environment | 9 (25.0) | |
Severe persistent allergic rhinitis | 35 (97.2) | |
Severe exacerbations in the last 12 months | 5 (1 to 20) | |
Allergic rhinitis score | 8 (0 to 18) | |
Gastroesophageal reflux disease | 7 (19.4) | |
Psychiatric disorder | 3 (8.3) | |
Smoking in the home (reported by the residents) | 12 (33.3) | |
Fully adherent to treatment | 2 (5.6) | |
Previous pulmonary function testing | 16 (44.4) | |
Incorrect inhaler technique | 13 (36) | |
Previous ICU admission | 7 (19.5) | |
Uncontrolled asthma (GINA criteria) | 36 (100) | |
Posology and medications in use | ||
Equivalent dose of budesonide (μg) | 800 (800 to 1200) | |
ICS alone | 9 (25.0) | |
ICS + LABA | 27 (75.0) | |
Leukotriene receptor antagonists | 4 (11.1) | |
Continuous oral ICS | 3 (8.3) | |
Omalizumab | 0 (0.0) |